A carregar...
Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?
Introduction: Fifty years after the discovery of Δ(9)-tetrahydrocannabinol (THC) as the psychoactive component of Cannabis, we are assessing the possibility of translating this herb into clinical treatment of inflammatory bowel diseases (IBDs). Here, a discussion on the problems associated with a po...
Na minha lista:
| Publicado no: | Expert Rev Gastroenterol Hepatol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5388177/ https://ncbi.nlm.nih.gov/pubmed/28276820 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17474124.2017.1292851 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|